INMB

INmune Bio (INMB)

INmune Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INMB

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/18	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/09/17	09 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INMB	INmune Bio Inc
2024/09/16	23 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/09/16	23 : 11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:INMB	INmune Bio Inc
2024/09/04	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/08/10	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/08/10	05 : 00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:INMB	INmune Bio Inc
2024/08/08	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:INMB	INmune Bio Inc
2024/08/03	05 : 01	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:INMB	INmune Bio Inc
2024/08/03	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/08/02	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INMB	INmune Bio Inc
2024/07/31	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/07/20	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/06/14	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/06/13	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INMB	INmune Bio Inc
2024/05/31	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/05/30	21 : 00	GlobeNewswire Inc.	INmune Bio Inc. to Join Russell 3000® Index	NASDAQ:INMB	INmune Bio Inc
2024/05/30	05 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:INMB	INmune Bio Inc
2024/05/24	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/05/17	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INMB	INmune Bio Inc
2024/05/17	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INMB	INmune Bio Inc
2024/05/17	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INMB	INmune Bio Inc
2024/05/17	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INMB	INmune Bio Inc
2024/05/17	05 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INMB	INmune Bio Inc
2024/05/17	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INMB	INmune Bio Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update	NASDAQ:INMB	INmune Bio Inc
2024/05/07	21 : 00	GlobeNewswire Inc.	INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9	NASDAQ:INMB	INmune Bio Inc
2024/04/30	21 : 00	GlobeNewswire Inc.	INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years	NASDAQ:INMB	INmune Bio Inc
2024/04/29	21 : 00	GlobeNewswire Inc.	INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer	NASDAQ:INMB	INmune Bio Inc
2024/04/25	22 : 00	GlobeNewswire Inc.	INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:INMB	INmune Bio Inc